Westlake
WLK NYSE Specialty Chemicals Financials FY2016–FY2025
Westlake's revenue fell 8.0% to $11.2 billion in fiscal 2025. Its operating margin was −14.1%, down from 7.2% a year earlier. Free cash flow was −$530 million, against $306 million a year earlier. It paid out $335 million in dividends and buybacks. The diluted share count fell 0.7%.
About these figures. Westlake's 2025 loss included large write-downs that made its EBITDA negative, so net debt to EBITDA is blank for that year.
What Westlake does
No business description yet.
- Legal name
- Westlake Corporation
- Fiscal year ends
- December 31, 2025
- Latest annual report
- —
- Accession · CIK
- 0001262823-26-000016
0001262823
Revenue and margins
Westlake had $11.2B of revenue in fiscal 2025, down 8.0% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was −$530M in fiscal 2025, −4.7% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Westlake returned $335M to shareholders in fiscal 2025. The diluted share count fell 0.7%.
Value Westlake yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets — the answer depends entirely on what you put in.
Discounted cash flow
Value per share
—
Adds net cash of −$2.9B and divides by 128.3M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Balance sheet
Cash, debt and the ratios that show how comfortably Westlake can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $1.9B | $2.2B | $3.3B | $2.9B | $2.7B |
| Debt incl. finance leases | $5.2B | $4.9B | $4.9B | $4.6B | $5.6B |
| Net debt / EBITDA | 0.9x | 0.7x | 0.9x | 0.8x | — |
| Debt / equity | 0.7x | 0.5x | 0.5x | 0.4x | 0.6x |
| Interest coverage | 15.9x | 17.2x | 4.4x | 5.5x | −9.2x |
| Current ratio | 2.3x | 2.6x | 2.4x | 2.8x | 2.2x |
| Quick ratio | 1.7x | 1.8x | 1.8x | 2.0x | 1.7x |
| Total assets | $18.5B | $20.6B | $21.0B | $20.8B | $20.0B |
| Total liabilities | $9.9B | $10.1B | $10.3B | $9.7B | $10.7B |
| Shareholders' equity | $8.0B | $9.9B | $10.2B | $10.5B | $8.8B |
| Net debt (− = net cash) | $3.3B | $2.7B | $1.6B | $1.6B | $2.9B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$10.2M
3 insiders
Of sales under plans
0%
$0.0M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Aug 11, 2026 | Albert ChaoExecutive Chairman, Director | Sold | 38,873 | $80.28 | $3.1M | Form 4 |
| Mar 27, 2026 | Mark Steven BenderEVP & CFO | Sold | 16,413 | $112.54 | $1.8M | Form 4 |
| Mar 27, 2026 | Robert F. BuesingerEVP, PEM Segment Head | Sold | 4,000 | $115.25 | $0.5M | Form 4 |
| Feb 27, 2026 | Mark Steven BenderEVP & CFO | Sold | 17,409 | $100.92 | $1.8M | Form 4 |
| Dec 22, 2025 | Albert ChaoExecutive Chairman, Director | Sold | 40,836 | $73.58 | $3.0M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | ✓ | ✓ | ✕ |
| Cash from operations is positive | ✓ | ✓ | ✓ |
| Return on assets rose | ✕ | ✓ | ✕ |
| Cash from operations exceeds net income | ✓ | ✓ | ✓ |
| Debt fell relative to assets | ✓ | ✓ | ✕ |
| Current ratio rose | ✕ | ✓ | ✕ |
| Share count didn't rise | ✓ | ✕ | ✓ |
| Gross margin rose | ✕ | ✕ | ✕ |
| Revenue rose relative to assets | ✕ | ✕ | ✕ |
| F-score | 5 / 9 | 6 / 9 | 3 / 9 |
| Accruals ratio | −8.9% | −3.4% | −9.7% |
| Altman Z'' | 4.10 | 4.39 | 2.94 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Westlake WLK | $8.3B | −8.0% | −14.1% | −4.7% | −10.0% | — | 3 | |
| International Flavors & Fragrances IFF | $24.2B | −5.2% | −3.5% | 2.4% | −1.4% | 82.6x | 6 | Compare → |
| Celanese CE | $5.3B | −7.1% | −8.2% | 8.4% | −3.7% | — | 5 | Compare → |
| Eastman Chemical EMN | $7.5B | −6.7% | — | 4.8% | 6.5% | 16.9x | 5 | Compare → |
| RPM International RPM | $12.6B | 6.7% | — | 8.6% | 13.9% | 18.3x | 6 | Compare → |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $5.1B | $8.0B | $8.6B | $8.1B | $7.5B | $11.8B | $15.8B | $12.5B | $12.1B | $11.2B |
| Gross profit | $983M | $1.8B | $2.0B | $1.3B | $1.0B | $3.5B | $4.1B | $2.2B | $2.0B | $813M |
| Operating income | $583M | $1.2B | $1.4B | $656M | $429M | $2.8B | $3.1B | $729M | $875M | −$1.6B |
| Interest expense | $79.0M | $159M | $126M | $124M | $142M | $176M | $177M | $165M | $159M | $171M |
| Pretax income | $558M | $1.1B | $1.3B | $570M | $331M | $2.7B | $2.9B | $700M | $938M | −$1.6B |
| Income tax | $138M | −$258M | $300M | $108M | −$42.0M | $607M | $649M | $178M | $291M | −$126M |
| Net income | $399M | $1.3B | $996M | $421M | $330M | $2.0B | $2.2B | $479M | $602M | −$1.5B |
| Diluted EPS | $3.06 | $10.00 | $7.62 | $3.25 | $2.56 | $15.58 | $17.34 | $3.70 | $4.64 | −$11.70 |
| Diluted shares | 0.13B | 0.13B | 0.13B | 0.13B | 0.13B | 0.13B | 0.13B | 0.13B | 0.13B | 0.13B |
| Cash flow | ||||||||||
| Cash from operations | $867M | $1.5B | $1.4B | $1.3B | $1.3B | $2.4B | $3.4B | $2.3B | $1.3B | $465M |
| Capital expenditure | $629M | $577M | $702M | $787M | $525M | $658M | $1.1B | $1.0B | $1.0B | $995M |
| Free cash flow | $238M | $951M | $707M | $514M | $772M | $1.7B | $2.3B | $1.3B | $306M | −$530M |
| Depreciation and amortization | $378M | $601M | $641M | $713M | $773M | $840M | $1.1B | $1.1B | $1.1B | $1.2B |
| Stock-based compensation | $14.0M | $23.0M | $22.0M | $25.0M | $29.0M | $31.0M | $36.0M | $43.0M | $41.0M | $41.0M |
| Acquisitions | $2.4B | $13.0M | $0.0M | $314M | $0.0M | $2.6B | $1.2B | $0.0M | $0.0M | $0.0M |
| Share buybacks | $67.0M | $0.0M | $106M | $30.0M | $54.0M | $30.0M | $101M | $23.0M | $60.0M | $63.0M |
| Dividends paid | $97.0M | $103M | $120M | $132M | $137M | $145M | $169M | $221M | $264M | $272M |
| Dividends and buybacks | $164M | $103M | $226M | $162M | $191M | $175M | $270M | $244M | $324M | $335M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $459M | $1.5B | $753M | $728M | $1.3B | $1.9B | $2.2B | $3.3B | $2.9B | $2.7B |
| Total debt | $3.8B | $3.8B | $2.7B | $3.5B | $3.6B | $5.2B | $4.9B | $4.9B | $4.6B | $5.6B |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Current assets | $2.4B | $3.5B | $2.8B | $2.7B | $3.5B | $5.3B | $6.0B | $6.6B | $6.2B | $6.2B |
| Current liabilities | $1.2B | $2.0B | $1.2B | $1.2B | $1.4B | $2.3B | $2.3B | $2.8B | $2.2B | $2.8B |
| Inventory | $801M | $900M | $1.0B | $936M | $918M | $1.4B | $1.9B | $1.6B | $1.7B | $1.7B |
| Property and equipment, net | $6.4B | $6.4B | $6.6B | $6.9B | $6.9B | $7.6B | $8.5B | $8.5B | $8.6B | $8.6B |
| Total assets | $10.9B | $12.1B | $11.6B | $13.3B | $13.8B | $18.5B | $20.6B | $21.0B | $20.8B | $20.0B |
| Total liabilities | $7.0B | $6.7B | $5.5B | $6.9B | $7.3B | $9.9B | $10.1B | $10.3B | $9.7B | $10.7B |
| Shareholders' equity | $3.5B | $4.9B | $5.6B | $5.9B | $6.0B | $8.0B | $9.9B | $10.2B | $10.5B | $8.8B |
| Margins | ||||||||||
| Gross margin | 19.4% | 21.9% | 23.0% | 15.5% | 13.6% | 29.7% | 25.8% | 17.7% | 16.1% | 7.3% |
| Operating margin | 11.5% | 15.2% | 16.3% | 8.1% | 5.7% | 23.8% | 19.3% | 5.8% | 7.2% | −14.1% |
| EBITDA margin | 18.9% | 22.7% | 23.7% | 16.9% | 16.0% | 30.9% | 26.0% | 14.6% | 16.4% | −3.6% |
| Net margin | 7.9% | 16.2% | 11.5% | 5.2% | 4.4% | 17.1% | 14.2% | 3.8% | 5.0% | −13.5% |
| FCF margin | 4.7% | 11.8% | 8.2% | 6.3% | 10.3% | 14.7% | 14.5% | 10.4% | 2.5% | −4.7% |
| Returns | ||||||||||
| Return on capital | 8.4% | 16.4% | 13.9% | 6.2% | 4.8% | 21.0% | 19.1% | 4.3% | 4.8% | −10.0% |
| Return on capital employed | 7.9% | 12.4% | 13.7% | 5.9% | 3.5% | 19.6% | 17.8% | 4.0% | 4.8% | −8.8% |
| Return on equity | 11.8% | 31.1% | 19.0% | 7.4% | 5.5% | 28.8% | 25.1% | 4.8% | 5.8% | −15.6% |
| Return on assets | 4.9% | 11.4% | 8.4% | 3.4% | 2.4% | 12.5% | 11.5% | 2.3% | 2.9% | −7.4% |
| Growth | ||||||||||
| Revenue growth | 4,584.6% | 58.4% | 7.4% | −6.0% | −7.6% | 57.0% | 34.1% | −20.6% | −3.2% | −8.0% |
| Net income growth | −38.2% | 226.8% | −23.6% | −57.7% | −21.6% | 510.6% | 11.5% | −78.7% | 25.7% | −350.5% |
| EPS growth | −37.0% | 226.8% | −23.8% | −57.4% | −21.2% | 508.6% | 11.3% | −78.7% | 25.4% | −352.2% |
| FCF growth | −59.5% | 299.6% | −25.7% | −27.3% | 50.2% | 124.9% | 31.7% | −43.1% | −76.5% | −273.2% |
| Share count change | −1.8% | −0.3% | 0.3% | −1.0% | −0.5% | 0.5% | 0.1% | −0.2% | 0.5% | −0.7% |
| Financial health | ||||||||||
| Net debt / EBITDA | 3.5x | 1.3x | 0.9x | 2.0x | 1.9x | 0.9x | 0.7x | 0.9x | 0.8x | — |
| Debt / equity | 1.1x | 0.8x | 0.5x | 0.6x | 0.6x | 0.7x | 0.5x | 0.5x | 0.4x | 0.6x |
| Interest coverage | 7.4x | 7.7x | 11.2x | 5.3x | 3.0x | 15.9x | 17.2x | 4.4x | 5.5x | −9.2x |
| Current ratio | 2.0x | 1.8x | 2.4x | 2.2x | 2.6x | 2.3x | 2.6x | 2.4x | 2.8x | 2.2x |
| Quick ratio | 1.4x | 1.3x | 1.6x | 1.5x | 1.9x | 1.7x | 1.8x | 1.8x | 2.0x | 1.7x |
| Capital allocation | ||||||||||
| Capex / revenue | 12.4% | 7.2% | 8.1% | 9.7% | 7.0% | 5.6% | 7.0% | 8.2% | 8.3% | 8.9% |
| Stock comp / revenue | 0.3% | 0.3% | 0.3% | 0.3% | 0.4% | 0.3% | 0.2% | 0.3% | 0.3% | 0.4% |
| Payouts / FCF | 68.9% | 10.8% | 32.0% | 31.5% | 24.7% | 10.1% | 11.8% | 18.7% | 105.9% | — |
| Quality scores | ||||||||||
| Piotroski F-score | 5.0 | 7.0 | 6.0 | 4.0 | 6.0 | 6.0 | 6.0 | 5.0 | 6.0 | 3.0 |
| Altman Z'' | 2.7 | 3.6 | 4.5 | 3.5 | 3.6 | 4.3 | 4.8 | 4.1 | 4.4 | 2.9 |
| Accruals ratio | −5.7% | −2.0% | −3.5% | −7.1% | −7.1% | −2.4% | −5.9% | −8.9% | −3.4% | −9.7% |
Source: SEC EDGAR XBRL filings (CIK 0001262823). Data updated October 14, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only — not investment advice. Check the original filings before relying on any figure.